Pilar Valdecantos M, Prieto Hontoria P, Pardo V, Módol T, Santamaría B, Weber M, et al. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radic Biol Med. 2015;84:263-278 pubmed publisher

Dho S, Deverman B, Lapid C, Manson S, Gan L, Riehm J, et al. Control of cellular Bcl-xL levels by deamidation-regulated degradation. PLoS Biol. 2013;11:e1001588 pubmed publisher

Mobasher M, Gonzalez Rodriguez A, Santamaria B, Ramos S, Martin M, Goya L, et al. Protein tyrosine phosphatase 1B modulates GSK3?/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity. Cell Death Dis. 2013;4:e626 pubmed publisher

Ishida S, Akiyama H, Umezawa Y, Okada K, Nogami A, Oshikawa G, et al. Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2. Oncotarget. 2018;9:26834-26851 pubmed publisher

Dho S, Manson S, Jung S, Lim J, Weintraub S. Bcl-xL deamidation is regulated by multiple ion transporters and is intramolecularly catalyzed. Biochim Biophys Acta Mol Cell Res. 2018;1865:995-1001 pubmed publisher

Santacatterina F, Sánchez Cenizo L, Formentini L, Mobasher M, Casas E, Rueda C, et al. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Oncotarget. 2016;7:490-508 pubmed publisher

Reiner T, de las Pozas A, Parrondo R, Palenzuela D, Cayuso W, Rai P, et al. Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage. Oncoscience. 2015;2:703-15 pubmed

Nogami A, Oshikawa G, Okada K, Fukutake S, Umezawa Y, Nagao T, et al. FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia. Oncotarget. 2015;6:9189-205 pubmed

Schaller Schönitz M, Barzan D, Williamson A, Griffiths J, Dallmann I, Battmer K, et al. BCR-ABL affects STAT5A and STAT5B differentially. PLoS ONE. 2014;9:e97243 pubmed publisher

Potter D, Kelly P, Denneny O, Juvin V, Stephens L, Dive C, et al. BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737. Neoplasia. 2014;16:147-57 pubmed publisher

Parrondo R, de las Pozas A, Reiner T, Perez Stable C. ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. Peerj. 2013;1:e144 pubmed publisher

Reiner T, Parrondo R, de las Pozas A, Palenzuela D, Perez Stable C. Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity. PLoS ONE. 2013;8:e56234 pubmed publisher

Valverde A, Miranda S, García Ramírez M, Gonzalez Rodriguez A, Hernandez C, Simo R. Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy. Mol Vis. 2013;19:47-53 pubmed

Martínez Palacián A, del Castillo G, Suárez Causado A, García Álvaro M, de Morena Frutos D, Fernandez M, et al. Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-?-induced oxidative stress and apoptosis. PLoS ONE. 2013;8:e53108 pubmed publisher

Thiel K, Hernandez L, Dassie J, Thiel W, Liu X, Stockdale K, et al. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res. 2012;40:6319-37 pubmed publisher